α-blockade and thiazide treatment of hypertension a double-blind randomized trial comparing doxazosin and hydrochlorothiazide

American Journal of Hypertension

Volumn 9, Issue 5, 1996, Pages 445-454

  Grimm Jr , Richard H ^a,e   Flack, John M ^b   Schoenberger, James A ^c   Gonzalez, Nelly M ^d   Liebson, Philip R ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d Allina Hospitals & Clinics   (United States)

^e HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Antihypertensive medication; Clinical trials; Hypertension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DOXAZOSIN; HIGH DENSITY LIPOPROTEIN; HYDROCHLOROTHIAZIDE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DIURETICS; DOUBLE-BLIND METHOD; DOXAZOSIN; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PULSE; QUALITY OF LIFE; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0029992345     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00439-4     Document Type: Article

References (18)

1. Collins R, Peto R, MacMahon S, et al: Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomized drug trials in the epidemiological context. Lancet 1990;335:827-838.
2. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program. JAMA 1991;265:3255-3264.
3. Dahlöf B, Lindholm LH, Hansson L, et al: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338(8778):1281-1285.
4. MRC Working Party: Medical Research Council Trial of Treatment of Hypertension in Older Adults: principal results. Br Med J 1992;304:405-412.
5. 1993 Joint National Committee: The fifth report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
6. Lipid Research Clinics Program Manual of Operations. Vol. 1. Lipid and Lipoprotein Analysis.US Department of Health Education and Welfare, Bethesda, MD, 1994. US Dept of Health, Education and Welfare publication no. 75-628.
7. Friedewald W, Levy R, Fredrickson D: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preoperative ultra-centrifuge. Clin Chem 1972;18:499-502.
8. Tarlov AR, Ware JE, Greenfield S, et al: The Medical Outcomes Study: an application of methods for monitoring the results of medical care. JAMA 1989; 262(7):925-930.
9. Prineas RJ, Crow R, Blackburn H: The Minnesota Code Manual of Electrocardiographic Findings. John Wright-PSG Inc., Littleton, MA, 1982, pp 1-229.
10. Liebson PR, Grandits G, Prineas R, et al: Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993;87(2):476-486.
11. Sahn DJ, Demuna A, Kisslo J, et al: The Committee on M-mode Standardization of the American Society of Echocardiography: Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
12. Devereux RB, Reichek N: Echocardiographic determinants of left ventricular mass in man. Circulation 1977;55:613-618.
13. Wilson JR, Reichek N, Hirshfeld J, Kollen CA: Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation. Am J Med 1980;68: 664-674.
14. Blake J, Devereaux RB, Harrold EM, et al: Relation of concentric left ventricular hypertrophy and extracardiac target orgen damage to supranormal left ventricular performance in established essential hypertension. Am J Cardiol 1988;62:246-252.
15. Stamler R, Stamler J, Gosch FC, et al: Initial antihypertensive drug therapy: αblocker or diuretic: interim report of a randomized, controlled trial. Am J Med 1986;80:90-93.
16. Grimm RH: α1 antagonist in the treatment of hypertension. Hypertension 1989;13(Suppl):1989;I131-I136.
17. The Treatment of Mild Hypertension Study Research Group. The Treatment of mild hypertension study: a randomized, placebo-controlled trial of a nutritionalhygienic regimen along with various drug monotherapies. Arch Intern Med 1991;151:1413-1423.
18. Neaton JD, Grimm RH, Prineas RJ, et al, for the Treatment of Mild Hypertension Study Research Group: The Treatment of Mild Hypertension Study: final results. JAMA 1993;270:(6):713-724.